EVOKE PHARMA INC (EVOK) Stock Analyst Ratings
USA - NASDAQ:EVOK - US30049G3020 - Common Stock
10.6998 USD
+0.01 (+0.09%)
ChartMill assigns a Buy % Consensus number of 83% to EVOK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.36. This target is 71.59% above the current price.
EVOK was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EVOK.
In the previous month the buy percentage consensus was at a similar level.
EVOK was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
EVOKE PHARMA INC / EVOK FAQ
What do analysts expect the price target to be for EVOKE PHARMA INC (EVOK)?
7 analysts have analysed EVOK and the average price target is 18.36 USD. This implies a price increase of 71.59% is expected in the next year compared to the current price of 10.6998.
What is the consensus rating for EVOK stock?
The consensus rating for EVOKE PHARMA INC (EVOK) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for EVOK stock?
The number of analysts covering EVOKE PHARMA INC (EVOK) is 7.